The use of AI will transform patient outcomes, report finds

By Catherine Sturman
Share
A recent report by Juniper Research has stated that not only will AI transform and shape the role in which digitisation will play within healthcare sect...

A recent report by Juniper Research has stated that not only will AI transform and shape the role in which digitisation will play within healthcare sector, the total spending on CAD (computer aided diagnosis) systems will reach $800.7 million by 2022.

It also adds that “by 2022, 28.4 million chronic disease scans will also be fed into first-line CAD systems annually.”

Large volumes of data routinely inputted into healthcare systems and Electronic Health Records (EHRs) will ultimately be harnessed in a bid to improve and provide exceptional patient centered care, as well as create an element of convenience with patients through implementing online booking systems, and the ability to speak to a medical professional, anytime, anywhere.

Related stories

The implementation of CAD systems will also provide the ability to look at certain trends within a number of chronic conditions through the use of diagnostics, and consequently lower costs across the board and enable acute healthcare settings to provide higher quality treatment options.

Nonetheless, with recent worldwide cyber-security attacks, such as the WannaCry attack involving the National Health Service in the United Kingdom, the need for IT infrastructures and cloud systems remains paramount within any risk analysis taken.

Current healthcare regulations under the European Union are consequently being revised, as well as the General Data Protection Regulation, which will become more specific and provide a more robust set of processes which businesses will need to follow.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma